| Primary |
| Pulmonary Arterial Hypertension |
56.5% |
| Cor Pulmonale Chronic |
24.0% |
| Pulmonary Hypertension |
13.0% |
| Product Used For Unknown Indication |
1.4% |
| Hypertension |
1.2% |
| Systemic Sclerosis |
0.8% |
| Primary Pulmonary Hypertension |
0.5% |
| Cor Pulmonale |
0.4% |
| Portal Hypertension |
0.3% |
| Essential Hypertension |
0.3% |
| Pulmonary Hypertension Secondary |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.2% |
| Chronic Pulmonary Heart Disease |
0.2% |
| Sarcoidosis |
0.2% |
| Scleroderma |
0.2% |
| Atrial Septal Defect |
0.1% |
| Back Pain |
0.1% |
| Hepatic Cirrhosis |
0.1% |
| Ph Body Fluid |
0.1% |
| Portopulmonary Hypertension |
0.1% |
|
| Death |
35.4% |
| Pneumonia |
12.8% |
| Dyspnoea |
9.7% |
| Pulmonary Arterial Hypertension |
5.0% |
| Syncope |
4.4% |
| Fluid Retention |
4.0% |
| Pulmonary Hypertension |
3.6% |
| Cardiac Failure Congestive |
3.5% |
| Fluid Overload |
2.4% |
| Chest Pain |
2.1% |
| Hypotension |
1.9% |
| Oedema |
1.8% |
| Epistaxis |
1.7% |
| Oxygen Saturation Decreased |
1.7% |
| Pulmonary Oedema |
1.7% |
| Respiratory Failure |
1.7% |
| Cerebrovascular Accident |
1.6% |
| Cough |
1.6% |
| Myocardial Infarction |
1.6% |
| Bronchitis |
1.5% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
44.9% |
| Product Used For Unknown Indication |
15.5% |
| Pulmonary Hypertension |
15.5% |
| Cor Pulmonale Chronic |
6.7% |
| Chronic Obstructive Pulmonary Disease |
4.0% |
| Cardiac Disorder |
1.7% |
| Sleep Apnoea Syndrome |
1.7% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Scleroderma |
1.2% |
| Atrial Septal Defect |
1.0% |
| Blood Pressure |
0.7% |
| Left Ventricular Failure |
0.7% |
| Pain |
0.7% |
| Anxiety |
0.5% |
| Bipolar Disorder |
0.5% |
| Connective Tissue Disorder |
0.5% |
| Drug Abuse |
0.5% |
| Hypertension |
0.5% |
| Hypothyroidism |
0.5% |
|
| Pulmonary Arterial Hypertension |
11.5% |
| Pneumonia |
9.6% |
| Dyspnoea |
8.7% |
| Death |
6.7% |
| Cough |
5.8% |
| Dizziness |
4.8% |
| Epistaxis |
4.8% |
| Lung Disorder |
4.8% |
| Syncope |
4.8% |
| Throat Irritation |
4.8% |
| Transfusion |
4.8% |
| Vomiting |
4.8% |
| Pulmonary Hypertension |
3.8% |
| Cardiac Failure Congestive |
2.9% |
| Fluid Retention |
2.9% |
| Hypotension |
2.9% |
| Hypoxia |
2.9% |
| Myocardial Infarction |
2.9% |
| Nasal Congestion |
2.9% |
| Oedema Peripheral |
2.9% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
43.6% |
| Product Used For Unknown Indication |
25.6% |
| Pulmonary Hypertension |
16.6% |
| Cor Pulmonale Chronic |
3.0% |
| Scleroderma |
2.5% |
| Connective Tissue Disorder |
1.2% |
| Heart Disease Congenital |
1.2% |
| Portopulmonary Hypertension |
1.1% |
| Systemic Lupus Erythematosus |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Sleep Apnoea Syndrome |
0.6% |
| Hypertension |
0.5% |
| Interstitial Lung Disease |
0.5% |
| Unevaluable Event |
0.5% |
| Hiv Infection |
0.4% |
| Rheumatoid Arthritis |
0.3% |
| Atrial Septal Defect |
0.3% |
| Diuretic Therapy |
0.3% |
| Drug Abuse |
0.3% |
| Hypoxia |
0.3% |
|
| Death |
21.5% |
| Pneumonia |
13.5% |
| Syncope |
9.8% |
| Dyspnoea |
6.8% |
| Pulmonary Arterial Hypertension |
6.4% |
| Cough |
4.5% |
| Vomiting |
4.5% |
| Pulmonary Hypertension |
3.7% |
| Urinary Tract Infection |
3.1% |
| Fluid Retention |
2.7% |
| Myocardial Infarction |
2.7% |
| Pyrexia |
2.7% |
| Transfusion |
2.7% |
| Pulmonary Oedema |
2.5% |
| Unevaluable Event |
2.5% |
| Heart Rate Increased |
2.3% |
| Oedema |
2.3% |
| Haemorrhage |
2.0% |
| Oedema Peripheral |
2.0% |
| Systemic Lupus Erythematosus |
2.0% |
|
